Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation.
Rudolph
Volker
V
1Department of General and Interventional Cardiology and Cardiovascular Research Center, University Heart Center, Hamburg, Germany.
Andrié
René P
RP
Rudolph
Tanja K
TK
Friedrichs
Kai
K
Klinke
Anna
A
Hirsch-Hoffmann
Birgit
B
Schwoerer
Alexander P
AP
Lau
Denise
D
Fu
Xiaoming
X
Klingel
Karin
K
Sydow
Karsten
K
Didié
Michael
M
Seniuk
Anika
A
von Leitner
Eike-Christin
EC
Szoecs
Katalin
K
Schrickel
Jan W
JW
Treede
Hendrik
H
Wenzel
Ulrich
U
Lewalter
Thorsten
T
Nickenig
Georg
G
Zimmermann
Wolfram-Hubertus
WH
Meinertz
Thomas
T
Böger
Rainer H
RH
Reichenspurner
Hermann
H
Freeman
Bruce A
BA
Eschenhagen
Thomas
T
Ehmke
Heimo
H
Hazen
Stanley L
SL
Willems
Stephan
S
Baldus
Stephan
S
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001281:Atrial Fibrillation / Q000201:enzymology* / Q000503:physiopathology; D006325:Heart Atria / Q000503:physiopathology; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects / Q000502:physiology; D008297:Male; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism / Q000502:physiology; D051379:Mice; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D009504:Neutrophils / Q000502:physiology; D009195:Peroxidase / Q000378:metabolism / Q000502:physiology*; D014443:Tyrosine / Q000031:analogs & derivatives / Q000097:blood / Q000378:metabolism
D000804:Angiotensin II; D014443:Tyrosine; D009195:Peroxidase; D020780:Matrix Metalloproteinase 9; C087259:3-chlorotyrosine